Number of patients with neoplastic lesions and the types of lesions identified
| CE group (n=66) | NBI group (n=65) | |
| Patients with neoplasia, n (%) | 14 (21.2%) | 14 (21.5%) |
| Total number of neoplastic lesions | 31 | 21 |
| Number of lesions according to histology | ||
| Carcinoma | 0 | 1 |
| High-grade dysplasia | 0 | 1 |
| Low-grade dysplasia | 30 | 19 |
| DALM | 2 | 0 |
| ALM | 12 | 9 |
| Serrated adenoma | 10 | 2 |
| Sporadic adenoma | 6 | 8 |
| Indefinite for dysplasia | 1 | 0 |
| Paris classification of the lesions | ||
| IIa | 15 (48%) | 13 (72%) |
| IIb | 2 (6%) | 0 |
| IIc | 0 | 0 |
| Is | 13 (42%) | 4 (22%) |
| Ip | 1 (4%) | 0 |
| IIa-c | 0 | 1 (6%) |
Per patient neoplasia detection rate p value: 0.96.
OR 1.02 (0.44 to 2.35).
ALM, adenoma-like mass; CE, chromoendoscopy; DALM, dysplasia-associated lesion or mass; NBI, narrow-band imaging.